Published in Proc Natl Acad Sci U S A on November 01, 1993
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A (1995) 4.54
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol (1996) 3.15
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol (1994) 2.59
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol (1994) 2.11
Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci U S A (1995) 1.81
Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol Cell Biol (2008) 1.77
Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol (1997) 1.75
A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest (2004) 1.71
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast Cancer Res (2012) 1.67
Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol (1997) 1.53
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J (1995) 1.48
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc Natl Acad Sci U S A (1995) 1.43
Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol (1998) 1.43
Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc Natl Acad Sci U S A (1995) 1.40
A cleavage-site-directed inhibitor of interleukin-1 beta-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochem J (1996) 1.34
Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol (1999) 1.30
Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev (1999) 1.27
Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol (1998) 1.24
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol Biol Cell (1996) 1.24
TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem (2010) 1.17
Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res (2000) 1.07
Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer (1997) 1.05
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol (1996) 1.02
A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development. Mol Cell Biol (2009) 0.97
TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF. Biochem Biophys Res Commun (2006) 0.95
Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med (1994) 0.94
Cell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction. Mol Cell Biol (2009) 0.94
Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. J Cell Biol (1995) 0.93
c-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation. J Biol Chem (2011) 0.93
Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis. Mol Cell Biol (1996) 0.92
Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci U S A (1994) 0.92
Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice. Hepatology (2011) 0.88
Activation of cyclin E-dependent kinase activity in colorectal cancer. Dig Dis Sci (2001) 0.87
Transforming growth factor beta-1 decreases the yield of the second meiotic division of rat pachytene spermatocytes in vitro. Reprod Biol Endocrinol (2005) 0.86
Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. Virchows Arch (2007) 0.82
Growth inhibition after exposure to transforming growth factor-β1 in human bladder cancer cell lines. Korean J Urol (2014) 0.80
MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma. J Transl Med (2015) 0.80
Abrogation of transforming growth factor-beta signaling in pancreatic cancer. World J Surg (2005) 0.79
Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells. Br J Cancer (1999) 0.78
Inhibition of spermidine synthase gene expression by transforming growth factor-beta 1 in hepatoma cells. Biochem J (1997) 0.78
Determining the effect of transforming growth factor-β1 on cdk4 and p27 in gastric cancer and cholangiocarcinoma. Oncol Lett (2012) 0.77
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
The transforming growth factor-beta family. Annu Rev Cell Biol (1990) 10.62
G1 events and regulation of cell proliferation. Science (1989) 9.73
A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A (1974) 8.74
Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell (1989) 8.19
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell (1991) 8.00
A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature (1991) 7.98
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (1990) 7.34
Cyclin activation of p34cdc2. Cell (1990) 6.87
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68
Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell (1991) 6.65
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell (1992) 6.08
Association of human cyclin E with a periodic G1-S phase protein kinase. Science (1992) 5.98
Human D-type cyclin. Cell (1991) 5.47
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell (1991) 4.88
Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36
Cyclins and cancer. Cell (1991) 3.65
Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (1989) 3.63
Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell (1990) 3.61
Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science (1993) 3.28
Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem Sci (1990) 3.20
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15
Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A (1992) 2.43
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci U S A (1990) 2.01
Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol (1991) 1.66
Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem (1992) 1.66
Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene (1993) 1.51
Modifications of cell cycle controlling nuclear proteins by transforming growth factor beta in the HaCaT keratinocyte cell line. Oncogene (1992) 0.94
Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem (1992) 0.93
The hallmarks of cancer. Cell (2000) 113.05
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
Mechanism of activation of a human oncogene. Nature (1982) 12.09
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev (2001) 11.25
Effects of an Rb mutation in the mouse. Nature (1992) 11.06
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (1993) 7.20
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell (1986) 7.06
Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol (1986) 7.06
Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell (1982) 6.93
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (1985) 6.23
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09
Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell (1995) 6.08
The integrated genome of murine leukemia virus. Cell (1978) 5.84
The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (1986) 5.77
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A (1979) 5.32
Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol (2000) 5.28
Acrylamide gel electrophoresis of HeLa cell nucleolar RNA. Proc Natl Acad Sci U S A (1967) 5.06
Small molecular weight monodisperse nuclear RNA. J Mol Biol (1968) 4.96
Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (1981) 4.72
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol (1998) 4.54
DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc Natl Acad Sci U S A (1981) 4.17
Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 4.16
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A (1998) 4.11
Isolation and characterization of simian virus 40 ribonucleic acid. J Virol (1972) 4.09
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (1996) 4.05
Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell (1979) 4.04
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet (1994) 3.97
A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection. Cell (1979) 3.74
Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A (1987) 3.72
Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc Natl Acad Sci U S A (1979) 3.64
The action of oncogenes in the cytoplasm and nucleus. Science (1985) 3.62
Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61
Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature (1997) 3.57
Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res (2001) 3.48
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev (2000) 3.30
Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26
A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A (1998) 3.23
Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol (1996) 3.15
Infectious viral DNA of murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.09
Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A (1995) 3.08
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci U S A (1975) 3.07
The pathway to signal achievement. Nature (1993) 3.03
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell (1983) 3.00
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci U S A (1997) 2.97
Structure of the intermediates leading to the integrated provirus. Biochim Biophys Acta (1977) 2.96
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene (1996) 2.96
Association between GTPase activators for Rho and Ras families. Nature (1992) 2.92
Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus. Cell (1992) 2.90
Expression cloning and characterization of the TGF-beta type III receptor. Cell (1991) 2.89
G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell (1991) 2.87
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature (1995) 2.87
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol (1986) 2.86
The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science (1985) 2.80
Three different human tumor cell lines contain different oncogenes. Cell (1981) 2.77
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell (1985) 2.75
The catalytic subunit of yeast telomerase. Proc Natl Acad Sci U S A (1997) 2.72
Processing of 45 s nucleolar RNA. J Mol Biol (1970) 2.60
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J (1988) 2.59
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J (1994) 2.57
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene (1998) 2.56
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet (1998) 2.56
Rescue of cyclin D1 deficiency by knockin cyclin E. Cell (1999) 2.54
Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination. J Virol (1981) 2.53
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol (1986) 2.52
Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 2.51
"Frizzy" aggregation genes of the gliding bacterium Myxococcus xanthus show sequence similarities to the chemotaxis genes of enteric bacteria. Proc Natl Acad Sci U S A (1989) 2.49
Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature (1995) 2.43
Nuclear RNA metabolism. Annu Rev Biochem (1973) 2.38
Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc Natl Acad Sci U S A (1988) 2.31
Simian virus 40 transcription in productively infected and transformed cells. J Virol (1974) 2.30
Genes involved in senescence and immortalization. Curr Opin Cell Biol (2000) 2.27
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26
Evidence for the Asiatic origin of endogenous AKR-type murine leukemia proviruses. J Virol (1980) 2.25
Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. Mol Cell Biol (1984) 2.24
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell (1982) 2.22
TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol (2001) 2.22
A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci U S A (1995) 2.20
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature (1986) 2.15
Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev (1994) 2.08
Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res (2001) 2.07
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A (1999) 2.06
In vitro synthesis of infectious DNA of murine leukaemia virus. Nature (1977) 2.06